glutamic acid has been researched along with Acute Coronary Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, HL; Liu, LZ; Wu, EP | 1 |
Friberg, Ö; Håkanson, E; Holm, J; Svedjeholm, R; Tajik, B; Vanky, F; Vidlund, M | 1 |
Borg, JO; Friberg, O; Håkanson, E; Holm, J; Juhl-Andersen, S; Sharma, R; Sunnermalm, L; Svedjeholm, R; Vanky, F; Vidlund, M | 1 |
2 trial(s) available for glutamic acid and Acute Coronary Syndrome
Article | Year |
---|---|
Post hoc analysis of the glutamics-trial: intravenous glutamate infusion and use of inotropic drugs after cabg.
Topics: Acute Coronary Syndrome; Aged; Cardiotonic Agents; Coronary Artery Bypass; Double-Blind Method; Epinephrine; Female; Glutamic Acid; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Ventricular Dysfunction, Left | 2016 |
GLUTAMICS--a randomized clinical trial on glutamate infusion in 861 patients undergoing surgery for acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Bypass; Double-Blind Method; Female; Glutamic Acid; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Prospective Studies; Risk Assessment; Risk Factors; Sodium Chloride; Sweden; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2012 |
1 other study(ies) available for glutamic acid and Acute Coronary Syndrome
Article | Year |
---|---|
Relation between K469E gene polymorphism of ICAM-1 and recurrence of ACS and cardiovascular mortality.
Topics: Acute Coronary Syndrome; Aged; Alleles; Asian People; Blood Glucose; Blood Pressure; China; Cholesterol, HDL; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Glutamic Acid; Humans; Intercellular Adhesion Molecule-1; Leucine; Lipids; Logistic Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Risk Reduction Behavior; Secondary Prevention | 2013 |